---
title: "SoftMedx Healthcare Sets 2026 AGM to Renew Share Issue and Buyback Mandates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285062661.md"
description: "SoftMedx Healthcare Limited has scheduled its annual general meeting for May 27, 2026, in Hong Kong. Shareholders will review financial statements and reports for the year ending December 31, 2025. The board seeks approval for directors' remuneration, reappointment of auditors, and renewal of mandates to issue up to 20% of share capital and repurchase up to 10%. These measures aim to enhance capital management flexibility and align with corporate governance practices. Approval would indicate continued shareholder support for the company's financial strategies."
datetime: "2026-05-04T11:12:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285062661.md)
  - [en](https://longbridge.com/en/news/285062661.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285062661.md)
---

# SoftMedx Healthcare Sets 2026 AGM to Renew Share Issue and Buyback Mandates

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest update is out from China Wah Yan Healthcare ( (HK:0648) ).

SoftMedx Healthcare Limited has called its annual general meeting for 27 May 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements and the directors’ and auditors’ reports for the year ended 31 December 2025. The board will also seek shareholder approval to set directors’ remuneration, reappoint Rongcheng (Hong Kong) CPA Limited as auditors, and renew mandates to issue up to 20% of its share capital and repurchase up to 10%, moves that preserve capital management flexibility and align with standard corporate governance practices for Hong Kong-listed issuers.

The proposed general mandate to issue new shares and the authority to repurchase existing shares would give the board additional tools to respond to funding needs and market conditions without convening separate meetings for each transaction. These resolutions, if passed, will remain effective until the next AGM or earlier revocation, and their approval would signal continued shareholder support for the company’s financial and capital structure strategies.

**More about China Wah Yan Healthcare**

SoftMedx Healthcare Limited is a Hong Kong-listed healthcare company, with its shares traded on the Stock Exchange of Hong Kong. The company operates under Hong Kong’s regulatory framework, maintaining audited consolidated financial statements and engaging external auditors to support transparency for investors and other stakeholders.

**Average Trading Volume:** 11,922,474

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$664.1M

### Related Stocks

- [00648.HK](https://longbridge.com/en/quote/00648.HK.md)

## Related News & Research

- [Transactions in connection with share buyback programme](https://longbridge.com/en/news/286732631.md)
- [If EPS Growth Is Important To You, Max Healthcare Institute (NSE:MAXHEALTH) Presents An Opportunity](https://longbridge.com/en/news/286866351.md)
- [Here's Why We Think Aster DM Healthcare (NSE:ASTERDM) Is Well Worth Watching](https://longbridge.com/en/news/286699738.md)
- [Cognizant increases 2026 buyback target to $2B with $2B authorization boost](https://longbridge.com/en/news/286769460.md)
- [CCI Group Leaves April Buybacks at Zero, Retains Ample Repurchase Capacity](https://longbridge.com/en/news/286196970.md)